Neuro Brain Factor Xstim
Natural health product licensed in Canada
- Other names
- Neuro Brain Factor XT
- Licence holder
- ATP ATHLÉTIQUE ET THÉRAPEUTIQUE PHARMA INC. ou ATP ATHLETIC AND THERAPEUTIC PHARMA INC.
- NPN or DIN-HM
- 80090384
- Status
- Inactive licence
- Licence date
- 30 January 2019
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Tyrosine Source : L-Tyrosine | 500 mg | Not calculated |
| Hericium erinaceus Source : Corps fructifère Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 5,000 mg Potency : 30 % Polysaccharides | 500 mg | Not calculated |
| Hericium erinaceus Source : Corps fructifère Potency : 15 % beta-glucan | Not specified | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : Acétyl-L-Carnitine | 500 mg | Not calculated |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 10 mg | Not calculated |
| L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline | 500 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 800 mcg | Not calculated |
| 1,3,7-triméthylxanthine Source : Camellia sinensis - feuille | 150 mg | Not calculated |
| 1,3,7-triméthylxanthine Source : Coffea canephora - Graine | 150 mg | Not calculated |
| 7,9-Dihydro-1,3,7,9-tétraméthyl-1H-purine-2,6,8(3H)-trione Source : Théacrine | 100 mg | Not calculated |
| [5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one Source : Huperzine A | 0.1 mg | Not calculated |
| Folate Source : L-5-methyltetrahydrofolate | 800 mcg | Not calculated |
Non-medicinal ingredients
Acide citrique, Feuille de Stevia rebaudiana, Saveur de fruit naturelle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to temporarily promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue. Helps to form red blood cells. Helps in energy metabolism and in tissue formation. Helps in the normal function of the immune system.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. May cause digestive problems.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome) . Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. f you have liver disease, kidney disease and/or a seizure disorder, consult a health care practitioner prior to use. If you have hear, vessel or blood pressure condition, consult a health care practitioner prior to use. If you experience dizziness, drowsiness, fatigue, insomnia, edema, heart palpitations, hypertension, increased sweating, muscle cramping and/or gastrointestinal symptoms such as nausea, vomiting, diarrhea or loss of appetite, discontinue use. If you are taking acetylcholinesterase inhibitors, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80090384
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.